60388-36-5,
4-(trifluoromethyl)-1,3-benzothiazol-2-amine,
4-(Trifluoromethyl)benzo[d]thiazol-2-amine,
2-Benzothiazolamine, 4-(trifluoromethyl)-,
4-(Trifluoromethyl)benzothiazol-2-amine,
4-Trifluoromethyl-benzothiazol-2-ylamine,
EINECS 262-211-6,
AC1Q4JUC,
AC1Q52YT,
AC1L353N,
SCHEMBL1913695,
DTXSID1069401,
CTK5B1417,
ZINC3888718,
MFCD00160038,
2-amino-4-trifluoromethylbenzothiazole,
AKOS000122824,
MCULE-4423080484,
SB18604,
4-(Trifluoromethyl)-2-benzothiazolamine,
2-Amino-4-(trifluoromethyl)benzothiazole,
2-Benzothiazolamine,4-(trifluoromethyl)-,
AJ-47329,
AN-39501,
AS-50398,
SC-32703,
2-Amino-4-(trifluoromethyl)-benzothiazole,
AB0003266,
CS-0054539,
FT-0652329,
EN300-12448,
W-2877,
388T365,
F2169-0129,
4-(trifluoromethyl)-1,3-benzothiazol-2-amine, AldrichCPR,
4- benzothiazol-2-amine,
C8H5F3N2S,
C8-H5-F3-N2-S,
AR-1D9017,
CID108937,
ZINC03888718,
2-Benzothiazolamine, 4-(trifluoromethyl)- (9CI),
4-(Trifluoromethyl)benzo[d]thiazol-2-amine, 97% - 1G 1g,
62143-18-4,